Vincent A. Fusaro

National Institutes of Health

Papers

1

Total Citations

114

H-Index

1

About

Vincent A. Fusaro is a pioneering figure in computational proteomics and cancer biomarker discovery, best known for integrating artificial intelligence with mass spectrometry to improve early cancer detection. His landmark 2004 study, cited over 114 times, demonstrated that serum proteomic profiling—using AI-driven pattern recognition algorithms on SELDI-TOF mass spectrometry data—could accurately discriminate prostate cancer from benign prostatic conditions in men with ambiguous PSA levels (2.5–15.0 ng/mL). This work addressed a critical clinical challenge: reducing unnecessary biopsies while improving diagnostic specificity. Fusaro’s contributions extend beyond prostate cancer; his research has advanced the use of machine learning to analyze complex proteomic data streams, enabling more precise, non-invasive diagnostics. By bridging computational biology and clinical oncology, he has helped lay the groundwork for personalized medicine approaches in cancer screening. His work remains highly influential among researchers developing AI-based diagnostic tools, and his methodologies continue to inform studies in proteomic pattern analysis and biomarker validation. Fusaro’s legacy lies in his vision of harnessing computational power to transform raw biological data into actionable clinical insights.

Research Focus

Key Achievements

1
H-Index
1
Papers
114
Total Citations
114
Avg Citations/Paper
🏆 Most Cited Paper
SERUM PROTEOMIC PROFILING CAN DISCRIMINATE PROSTATE CANCER FROM BENIGN PROSTATES IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2.5 AND 15.0 NG/ML
114 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago